metered dose inhaler
Showing 1 - 25 of >10,000
Asthma Trial in Saskatoon (salbutamol aqueous solution, salbutamol pressurized metered dose inhaler, )
Not yet recruiting
- Asthma
- salbutamol aqueous solution
- +2 more
-
Saskatoon, Saskatchewan, CanadaAsthma Research Lab University of Saskatchewan Room 346 Ellis Ha
Jul 26, 2023
Asthma, Patient Education Trial in Gaziantep (Demonstration method for the use of the Metered Dose Inhaler, Video watching
Not yet recruiting
- Asthma
- Patient Education
- Demonstration method for the use of the Metered Dose Inhaler
- Video watching method for the use of the Metered Dose Inhaler
-
Gaziantep, TurkeyHasan Kalyoncu University
Dec 6, 2022
Asthma Trial in Spartanburg (Fluticasone propionate pressurized metered dose inhaler, Flovent HFA pressurized metered dose
Completed
- Asthma
- Fluticasone propionate pressurized metered dose inhaler
- +2 more
-
Spartanburg, South CarolinaSite 1
Aug 31, 2021
Bronchial Asthma Trial in Chandigarh (Single Inhalation technique, Tidal inhalation technique)
Recruiting
- Bronchial Asthma
- Single Inhalation technique
- Tidal inhalation technique
-
Chandigarh, India
- +1 more
Jun 23, 2022
Asthma Trial (SCH 32088 mometasone furoate (MF) metered-dose inhaler, Placebo metered-dose inhaler BID)
Withdrawn
- Asthma
- SCH 32088 mometasone furoate (MF) metered-dose inhaler
- Placebo metered-dose inhaler BID
- (no location specified)
Feb 7, 2022
Asthma Trial in United States (Albuterol dry powder inhaler, Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler))
Completed
- Asthma
- Albuterol dry powder inhaler
- Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler)
-
Los Angeles, California
- +8 more
Jan 18, 2022
Symptom and Quality of Life in COPD by
Recruiting
- Pulmonary Disease, Chronic Obstructive
-
Nagoya, Aichi, Japan
- +16 more
Jan 17, 2023
Asthma Trial in Worldwide (BFF MDI 160/9.6 µg BID (320/19.2µg/day), BD MDI 160 µg BID (320 µg/day))
Recruiting
- Asthma
- BFF MDI 160/9.6 μg BID (320/19.2μg/day)
- BD MDI 160 μg BID (320 μg/day)
-
Huntington Beach, California
- +52 more
Mar 9, 2023
Asthma Trial (Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI, Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5
Completed
- Asthma
- Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI
- Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5 mcg MDI
- (no location specified)
Feb 7, 2022
Exercise Induced Bronchospasm Trial in United States (Budesonide/albuterol sulfate metered-dose inhaler 160/180 µg, Placebo
Completed
- Exercise Induced Bronchospasm
- Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg
- Placebo metered-dose inhaler
-
Denver, Colorado
- +5 more
Jan 4, 2022
Pharmacokinetics Trial in San Antonio (Beclomethasone dipropionate BAI, Beclomethasone dipropionate MDI)
Completed
- Pharmacokinetics
- Beclomethasone dipropionate BAI
- Beclomethasone dipropionate MDI
-
San Antonio, TexasTeva Investigational Site
Nov 5, 2021
Real-world, 52-week Prospective Study to Capture Reasons for
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive (COPD)
- Budesonide Glycopyrronium bromide Formoterol fumarate pressurized Metered Dose Inhaler
- (no location specified)
Jun 13, 2023
COPD Trial in Batman, Mersin (VIDEO-TRAINING-SESSION ABOUT MDI USE)
Completed
- Chronic Obstructive Pulmonary Disease
- VIDEO-TRAINING-SESSION ABOUT MDI USE
-
Batman, Turkey
- +1 more
Sep 7, 2021
Asthma, COPD Trial (SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F ))
Completed
- Asthma
- COPD
- SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F )
- (no location specified)
Feb 7, 2022
Asthma Trial (Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI)
Completed
- Asthma
- Mometasone furoate/formoterol (MF/F) MDI
- Fluticasone propionate/salmeterol (F/SC) DPI
- (no location specified)
Feb 7, 2022
Mucociliary Clearance Trial in United States (HFO MDI, HFA MDI)
Not yet recruiting
- Mucociliary Clearance
- HFO MDI
- HFA MDI
-
San Diego, California
- +4 more
Feb 23, 2023
Asthma Trial (MF/F Metered Dose Inhaler (MDI) 25/5 mcg, MF/F MDI 50/5 mcg, MF/F MDI 100/5 mcg)
Withdrawn
- Asthma
- MF/F Metered Dose Inhaler (MDI) 25/5 mcg
- +6 more
- (no location specified)
Feb 7, 2022
Mild Persistent Asthma Trial in London (BDP/formoterol, Placebo)
Completed
- Mild Persistent Asthma
- BDP/formoterol
- Placebo
-
London, United KingdomRespiratory Clinical Trials - Heart Lung Centre - Queen Anne Str
Oct 28, 2021
Asthma Trial in Denver (Qvar, Flovent Diskus)
Terminated
- Asthma
- Qvar
- Flovent Diskus
-
Denver, ColoradoNational Jewish Medical and Research Center
Nov 19, 2021
Asthma, COPD Trial in London (Therapeutic Dose 1, Therapeutic Dose 2, Supra-therapeutic Dose)
Completed
- Asthma
- Chronic Obstructive Pulmonary Disease
- Therapeutic Dose 1
- +3 more
-
London, Tooting, United KingdomRichmond Pharmacology Ltd
Oct 15, 2021
Asthma, Asthma in Children Trial in Coleraine, Derry / Londonderry (aflo™ digital respiratory management platform, Standard
Recruiting
- Asthma
- Asthma in Children
- aflo™ digital respiratory management platform
- Standard care
-
Coleraine, N.Ireland, United Kingdom
- +1 more
Feb 14, 2023
COVID-19 Trial in Buffalo (Ciclesonide, Placebo)
COPD Trial in Manchester (CHF 1535 NEXThaler 800/48, CHF 1535 NEXThaler 200/12, CHF 1535 NEXThaler PLACEBO)
Completed
- COPD
- CHF 1535 NEXThaler 800/48
- +4 more
-
Manchester, United KingdomMedicine Evaluation Unit
Oct 28, 2021